Renalytix AI (RNLX) Reports Unsolicited Approach from Possible Strategic Acquiror

 Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care provides the following update in regard to an unsolicited approach from a possible strategic acquiror, launch of a Formal Sale Process, and its advanced financing activities.

https://www.streetinsider.com/8K/Renalytix+AI+%28RNLX%29+Reports+Unsolicited+Approach+from+Possible+Strategic+Acquiror%2C+Launch+of+Formal+Sale+Process%2C+and+Update+on+Financing/22874682.html